211623 Can real health care reform be achieved in a for-profit system?

Tuesday, November 10, 2009: 10:50 AM

Laura Turiano, MS, PA-C , Right to Health and Health Care Campaign, People's Health Movement, Berkeley, CA
Accessible health care for all and decreased costs are the goals of current health care reform efforts, but the pharmaceutical, and insurance companies and private health care institutions health care reform is a chance to shift public money to subsidize private profits. While many are demanding Medicare For All as an immediate, practical step to a national single-payer system, much of Medicare and Medicaid has been subcontracted out to private insurers and Medicare Part D has proven to be a huge give-away to the drug companies. These same interests are undermining universal health care systems in other countries. Front-line health practitioners witness daily how the current, profit driven health care system and increasing inequality create barriers to health and are destructive of the things we truly value.

Learning Objectives:
1. Describe how private insurers, giant Pharma and the private health industry in general is trying to subvert and derail health reform 2. Explain why the current, profit driven health care system and increasing inequality create barriers to health and are destructive of the things we truly value

Keywords: Health Reform, National Health Insurance

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a family practice physician assistant who has practiced in a community health center and an addiction treatment program in Oakland, California, and in El Salvador. I currently serve on the global coordination group of the People's Health Movement (PHM) Right to Health and Health Care Campaign and on the coordination committee of the PHM-USA.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.